Navigation Links
European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Date:4/1/2008

process for XYOTAX," said James A. Bianco, M.D., President and CEO of CTI. "This is an important step toward making XYOTAX available for lung cancer patients in Europe."

About Lung Cancer

Lung cancer is the most common malignancy worldwide. Non-small cell lung cancer (NSCLC) accounts for 80 percent of all lung cancer cases. Within the population of patients with NSCLC requiring chemotherapy, PS2 patients, which account for approximately 25 percent of this group, are a population with special requirements since they have poor survival with cytotoxic chemotherapy and targeted agents. PS2 patients represent a subgroup of patients who are ambulatory and capable of self-care, but are unable to carry out any work activities, although they are up and about more than 50 percent of waking hours. There are presently no drugs approved to treat PS2 patients with advanced NSCLC.

Lung cancer remains the biggest cancer killer in Europe. The incidence of lung cancer in Europe is more than 13 percent of all cancers, and in 2000 resulted in nearly 350,000 deaths.

About XYOTAX(TM)

XYOTAX(TM) (paclitaxel poliglumex, CT-2103) is an investigational, biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal tissue's exposure to high levels of unbound, active chemotherapy and its associated toxicities. Blood vessels in tumor tissue, unlike blood vessels in normal tissue, are porous to molecules like polyglutamate. Based on preclinical studies, it appears that XYOTAX is preferentially distributed to tumors due to their leaky blood vessels and trapped in the tumor bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer,
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Leaf Healthcare releases ... pressure ulcers place on the healthcare system . ... threat to modern quality healthcare. Research by the ... for Healthcare Research and Quality shows that pressure ... $11 billion a year. The condition is both ...
(Date:7/28/2015)... Mass. , July 28, 2015  Today, Sekisui ... A compact, affordable and efficient instrument, with a broad ... bring significant benefits to the physicians, office or hospital ... of up to 580 tests/hour with ISE, 72 patient ... and has 36 onboard assays (+3 ISE) to meet ...
(Date:7/28/2015)... 28, 2015 Voalte, the leader in ... in purpose-built wireless communications, today announced that Bay ... 104-bed acute-care facility in Webster, Texas ... One™ solution on Spectralink PIVOT™ purpose-built smartphones for ... Voalte a member of its AIMS Partner Program ...
Breaking Medicine Technology:Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3
... ongoing randomized chemotherapy combination trials to ... of specific cancers -, ROCKVILLE, Md., Sept. 2 ... reported initial topline results from,an ongoing randomized Phase 2 ... combination with bortezomib (Velcade) in patients,with advanced multiple myeloma. ...
... Cardiology Continue ... to Innovative Technology, CARLSBAD, Calif., Sept. 2 ... its innovative atrial,fibrillation ablation products were presented by Dr. ... at the European Society of,Cardiology (ESC) congress. One of ...
Cached Medicine Technology:Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 2Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 3Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 5Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 6Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies 2Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies 3
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces Shelled Out, a new household invention that makes shelling eggs an exact ... by 2020,” says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
(Date:7/28/2015)... ... 2015 , ... Darryl Worley’s Annual Tennessee River Run events ... of raising money for the Darryl Worley Foundation. Worley will host Wade Hayes, ... Saturday, Oct. 3. , This year’s concert will have a second stage showcasing ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part ... and one of the first five hospitals in the nation, to implant the newly ... on July 23, and all are in good condition. , The CoreValve® Evolut® R ...
(Date:7/28/2015)... ... 28, 2015 , ... Representatives with CareMed Urgent & Primary ... of National Immunization Awareness Month, which is the month of August. , “Immunization ... like the flu, measles, and pneumonia, adults need to get their shots – ...
(Date:7/28/2015)... ... July 16, 2015 (PRWEB) July 28, 2015 , ... ... that specializes in providing Health insurance quotes to its clients, recently announced the ... insurance rates that best suits their specific needs. , Liability automobile insurance ...
Breaking Medicine News(10 mins):Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2
... doctors in Tamilnadu said that the doctors in Delhi ... duty. Hence it is asking the doctors to call ... of Institute of Thoracic Medicine, Tambaram, said that though ... proposed reservation in elite educational institutions, it said that ...
... vital that children are administered the correct dosage of ... a hospital.// A new study presented at the Society ... error rates in a program called "LA Kids." ... a Broselow tape (a weight-estimating tool) and report weight-based ...
... get themselves screened for HIV, city-run medical clinics have relaxed ... the new rule, counseling sessions and written informed consent is ... is a verbal consent from the patient. ,This ... relaxed with respect to consent and counseling. Two hospitals and ...
... discovered an embezzlement of nearly Rs.4.4 million from funds ... the fund use were discovered during checking of records ... education. ,The embezzlement was done by four ... 1997 and March 2005. ,Out of this, ...
... for the Indian School Certificate Examination (CISCE) declared the results ... Wednesday// with girls outshining boys for the second consecutive year. ... examination was 96.9 as against 95.29 among boys. Similarly, in ... compared to 91 percent among the boys. ...
... of premature infants from damage. An ongoing study, which ... an early finding in a trial being undertaken to ... of apnoea of prematurity. ,Apnoea of prematurity ... are underdeveloped and the central nervous system, which automatically ...
Cached Medicine News:Health News:Children Need Different Dosage In Cardiac Arrest 2Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2
... Lab QMS (Quality Management System) is ... built specifically for healthcare labs. The ... you meet quality management and accreditation/auditing ... has more time to devote to ...
... laboratory microscope from Carl Zeiss combines ... research-class instruments with a user-friendly ergonomic ... routine clinical applications in pathology, histology, ... has numerous applications in fluorescence microscopy, ...
... easy to operate and maintain. The units ... flexible snap-seal pockets which minimize the potential ... the water. Offered in two-, four-, and ... bags of various sizes. ThermoLine Thawing Systems ...
... Thawing Systems from Helmer use both controlled temperature ... ensuring the safety of your plasma. The DH4 ... dual baskets with independent controls that will accommodate ... is also convenient to operate, allowing you to ...
Medicine Products: